BioLife Solutions, Inc.

NasdaqCM:BLFS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

📦 Containers & Packaging

🚚 Logistics & Freight

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 1.04 B

Share Price

USD 21.82

Avg Daily Volume

560,335

Change (1 day)

-1.27%

Change (1 year)

-9.23%

Change (YTD)

-15.95%

BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -25.13%

BioLife Solutions, Inc. EBIT Margin is -25.13% for the Trailing 12 Months (TTM) ending September 30, 2024, a -39.21% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -41.34%, a -42.66% change year over year.
BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -72.11%, a 157.35% change year over year.
BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -28.02%, a -17.13% change year over year.
BioLife Solutions, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -33.81%, a -538.73% change year over year.